Journal article icon

Journal article

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes

Abstract:

Objective- The efficacy and safety of adding liraglutide (a glucagon-like peptide-1 receptor agonist) to metformin were compared with addition of placebo or glimepiride to metformin in subjects previously treated with oral antidiabetes (OAD) therapy. Research design and methods- In this 26-week, double-blind, double-dummy, placebo- and active-controlled, parallel-group trial, 1,091 subjects were randomly assigned (2:2:2:1:2) to once-daily liraglutide (either 0.6, 1.2, or 1.8 mg/day injected s...

Expand abstract

Actions


Access Document


Publisher copy:
10.2337/dc08-1355

Authors


Expand authors...
Journal:
Diabetes Care
Volume:
32
Issue:
1
Pages:
84-90
Publication date:
2009-01-01
DOI:
EISSN:
1935-5548
ISSN:
0149-5992
Source identifiers:
95008
Language:
English
Pubs id:
pubs:95008
UUID:
uuid:8c284677-66f0-4e58-9b91-485f893c2811
Local pid:
pubs:95008
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP